T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily

International Immunology

Volumn 18, Issue 7, 2006, Pages 1179-1188

  Lichterfeld, Mathias ^a   Williams, Katie L ^a   Mui, Stanley K ^a   Shah, Shivani S ^a   Mothe, Bianca R ^b   Sette, Alessandro ^c   Kim, Arthur ^a   Johnston, Mary N ^a   Burgett, Nicole ^a   Frahm, Nicole ^a   Cohen, Daniel ^d   Brander, Christian ^a   Rosenberg, Eric S ^a   Walker, Bruce D ^a,e   Altfeld, Marcus ^a   Yu, Xu G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d Fenway Community Health   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Cross presentation; Cross recognition; Cytotoxic T cells; HIV 1; HLA A3 superfamily

Indexed keywords

EPITOPE; HLA A3 ANTIGEN; T LYMPHOCYTE RECEPTOR; TETRAMER; VIRUS PROTEIN;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BETA CHAIN; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN VARIANT; T LYMPHOCYTE;

ALLELES; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, NEF; GENES, T-CELL RECEPTOR BETA; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HLA-A3 ANTIGEN; HUMANS;

EID: 33745278100     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl052     Document Type: Article

References (36)

1. Sidney, J., Grey, H. M., Kubo, R. T. and Sette, A. 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 17:261.
2. Sidney, J., Grey, H. M., Southwood, S. et al. 1996. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptidebinding repertoires of common HLA molecules. Hum. Immunol. 45:79.
3. Barber, L. D., Gillece-Castro, B., Percival, L., Li, X., Clayberger, C. and Parham, P. 1995. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr. Biol. 5:179.
4. Rammensee, H. G., Friede, T. and Stevanoviic, S. 1995. MHC ligands and peptide motifs: First listing. Immunogenetics 41:178.
5. Tallquist, M. D., Yun, T. J. and Pease, L. R. 1996. A single T cell receptor recognizes structurally distinct MHC/peptide complexes with high specificity. J. Exp. Med. 184:1017.
6. Aparicio, P., Jaraquemada, D. and Lopez de Castro, J. A. 1987. Alloreactive cytolytic Tcell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective involvement of CD8 in their class I-directed cytotoxicity. J. Exp. Med. 165:428.
7. Tomiyama, H., Yamada, N., Komatsu, H., Hirayama, K. and Takiguchi, M. 2000. A single CTL clone can recognize a naturally processed HIV-1 epitope presented by two different HLA class I molecules. Eur. J. Immunol. 30:2521.
8. Ueno, T., Tomiyama, H. and Takiguchi, M. 2002. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules. J. Immunol. 169:4961.
9. Sette, A. and Sidney, J. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201.
10. Li, L. and Bouvier, M. 2005. Biochemical and structural impact of natural polymorphism in the HLA-A3 superfamily. Mol. Immunol. 42:1331.
11. Lichterfeld, M., Yu, X. G., Waring, M. T. et al. 2004. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-(gamma) and tumor-necrosis factor-(alpha). Blood. 104:487.
12. Sidney, J., Southwood, S., Oseroff, C., Del Guercio, M.-F. and Sette, A. 1998. Measurement of MHC/peptide interactions by gel filtration. Curr. Prot. Immunol. 18:18.3.2.
13. Lichterfeld, M., Yu, X. G., Cohen, D. et al. 2004. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. Aids 18:1383.
14. Goulder, P. J., Addo, M. M., Altfeld, M. A. et al. 2001. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by Elispot and intracellular cytokine staining assays. J. Virol. 75:1339.
15. Douek, D. C., Betts, M. R., Brenchley, J. M. et al. 2002. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 168:3099.
16. Utz, U., Banks, D., Jacobson, S. and Biddison, W. E. 1996. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: Evidence for oligoclonal expansion. J. Virol. 70:843.
17. Lefranc, M. P., Pommie, C., Ruiz, M. et al. 2003. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev. Comp. Immunol. 27:55.
18. Wang, X. L. and Altman, J. D. 2003. Caveats in the design of MHC class I tetramer/antigen-specific T lymphocytes dissociation assays. J. Immunol. Methods 280:25.
19. Savage, P. A., Boniface, J. J. and Davis, M. M. 1999. A kinetic basis for Tcell receptor repertoire selection during an immune response. Immunity 10:485.
20. Couillin, I., Culmann-Penciolelli, B., Gomard, E. et al. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180:1129.
21. Sriwanthana, B., Hodge, T., Mastro, T. D. et al. 2001. HIV-specific cytotoxic T lymphocytes, HLA-A11, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand. AIDS Res. Hum. Retrovir. 17:719.
22. Padovan, E., Giachino, C., Cella, M., Valitutti, S., Acuto, O. and Lanzavecchia, A. 1995. Normal T lymphocytes can express two different T cell receptor beta chains: Implications for the mechanism of allelic exclusion. J. Exp. Med. 181:1587.
23. Brander, C. and Goulder, P. 2001. The identification of optimal HIV-derived CTL epitopes in diverse populations using HIV clade-specific consensus. In Korber, B. T., Brander, C., Haynes, B. F., Koup, R., Kuiken, C., Moore, J. P.,Walker, B. D.,Watkins, D. I., eds, HIV Molecular Database. Los Alamos National Laboratory, Los Alamos, New Mexico.
24. Threlkeld, S. C., Wentworth, P. A., Kalams, S. A. et al. 1997. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: Implications for vaccine development. J. Immunol. 159:1648.
25. Missale, G., Redeker, A., Person, J. et al. 1993. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751.
26. Levitsky, V., Liu, D., Southwood, S., Levitskaya, J., Sette, A. and Masucci, M. G. 2000. Supermotif peptide binding and degeneracy of MHC: peptide recognition in an EBV peptide-specific CTL response with highly restricted TCR usage. Hum. Immunol. 61:972.
27. Wang, R. F., Johnston, S. L., Southwood, S., Sette, A. and Rosenberg, S. A. 1998. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33. J. Immunol. 160:890.
28. Bertoni, R., Sidney, J., Fowler, P., Chesnut, R. W., Chisari, F. V. and Sette, A. 1997. Human histocompatibility leukocyte antigenbinding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100:503.
29. Kawashima, I., Tsai, V., Southwood, S., Takesako, K., Celis, E. and Sette, A. 1998. Identification of gp100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells. Int. J. Cancer 78:518.
30. Padovan, E., Casorati, G., Dellabona, P., Meyer, S., Brockhaus, M. and Lanzavecchia, A. 1993. Expression of two Tcell receptor alpha chains: dual receptor T cells. Science 262:422.
31. Davodeau, F., Peyrat, M. A., Romagne, F. et al. 1995. Dual T cell receptor beta chain expression on human T lymphocytes. J. Exp. Med. 181:1391.
32. Garcia, K. C., Degano, M., Stanfield, R. L. et al. 1996. An alphabeta Tcell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274:209.
33. Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E. and Wiley, D. C. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
34. Li, L. and Bouvier, M. 2004. Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue. J. Immunol. 172:6175.
35. Molloy, P. E., Sewell, A. K. and Jakobsen, B. K. 2005. Soluble T cell receptors: Novel immunotherapies. Curr. Opin. Pharmacol. 5:438.
36. Cooper, L. J., Kalos, M., Lewinsohn, D. A., Riddell, S. R. and Greenberg, P. D. 2000. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J. Virol. 74:8207.